Rank |
Status |
Study |
1 |
Unknown †
|
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer
Conditions: |
Prostate Cancer; Androgen Deprivation Therapy; Osteoporosis |
Intervention: |
Procedure: blood sampling, DXA-scan, bone scintigraphy |
Outcome Measure: |
Osteoporosis, either T-score < -2,5 or Osteoporosis fracture |
|
2 |
Recruiting
|
Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
Condition: |
Osteoporosis With Current Fragility Fracture |
Intervention: |
Behavioral: Osteoporosis prevention program |
Outcome Measures: |
Proportion of women in the 2 groups who initiated a management of Osteoporosis at 6 months (BMD or Osteoporosis treatment prescription).; Proportion of women in the two groups who performed BMD at 6 months; Proportion of women in the two groups with an increased perception of fracture risk.; Proportion of women in the two groups who changed their behaviour in order to prevent future fractures: regular practice of physical activity, dairy products consumption and calcium and vitamin D supplementation.; Proportion of women who improved their knowledge about Osteoporosis |
|
3 |
Unknown †
|
Osteoporosis Coordinator for Low Volume Community Hospitals
Conditions: |
Osteoporosis; Fragility Fractures |
Interventions: |
Behavioral: centralized Osteoporosis coordinator; Behavioral: fall prevention |
Outcome Measures: |
proportion of patients from the intervention group as compared to the control group that had "appropriate management" based on a composite of undergoing a BMD test and starting therapy within 6 months of fracture.; Osteoporosis knowledge, perceived susceptibility, self-efficacy, preventive behaviors; participants' experience and perceptions of future fracture risk; their understanding of the educational materials and acceptance of recommended treatment plans. |
|
4 |
Recruiting
|
Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Condition: |
Adult Idiopathic Generalized Osteoporosis |
Interventions: |
Drug: Teriparatide; Drug: Saline Placebo |
Outcome Measure: |
Change in lumbar spine bone mineral density (LS-BMD) |
|
5 |
Recruiting
|
Study on the microRNA Expression Level in Postmenopausal Osteoporosis
Condition: |
Postmenopausal Osteoporosis |
Intervention: |
Other: Osteoporosis |
Outcome Measure: |
microRNA expression lever in the Peripheral Blood |
|
6 |
Recruiting
|
Age Dependend Diagnostic Thresholds for Osteoporosis Bindex Ultrasonometer
Condition: |
Osteoporosis |
Intervention: |
|
Outcome Measure: |
Thresholds for Bindex in Osteoporosis Diagnostics |
|
7 |
Unknown †
|
Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis
Condition: |
Osteoporosis |
Intervention: |
|
Outcome Measure: |
|
|
8 |
Recruiting
|
Osteoporosis in RETT Syndrome
Condition: |
RETT Syndrome With Proven MECP2 Mutation |
Intervention: |
Other: biological markers and evaluation of the mineral density at the lumber spine using DEXA |
Outcome Measures: |
Osteoporosis in RETT patients; Biological Mechanisms of Osteoporosis |
|
9 |
Unknown †
|
A Interventional Study of Geriatric Frailty, Osteoporosis, and Depression
Conditions: |
Frailty; Osteoporosis; Depression |
Intervention: |
|
Outcome Measures: |
Including physical health, mental health, social functioning, quality of life, daily functioning, and health care resource utilizations. Feasibility analysis is applied to assess the possibility for large scale disseminations of the proposed project.; The results of the proposed study will help shaping the geriatric healthcare policy toward the goal of "active aging" in Taiwanese community-dwelling elders. |
|
10 |
Recruiting
|
Gaining Optimal Osteoporosis Assessments in Long-Term Care (GOAL)
Condition: |
Osteoporosis |
Intervention: |
Other: Knowledge Translation Education Sessions |
Outcome Measures: |
Difference in the percentage of residents appropriately prescribed an Osteoporosis medication before and after the intervention.; Difference in the percentage of residents prescribed Vitamin D (equivalent to ≥800 IU/day) before and after the intervention. |
|
11 |
Not yet recruiting
|
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Condition: |
Osteoporosis |
Intervention: |
Other: Questionnaires about compliance and persistence with bisphosphonates treatment |
Outcome Measure: |
Compliance and persistence to Osteoporosis drug therapy |
|
12 |
Recruiting
|
Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
Condition: |
Osteoporosis |
Intervention: |
Drug: Teriparatide |
Outcome Measures: |
BMD at Hip and lumber spine; Reduction in fracture risk |
|
13 |
Recruiting
|
Improved Screening for Osteoporosis
Condition: |
Osteoporosis |
Intervention: |
|
Outcome Measure: |
Number of patients screened at risk for Osteoporosis |
|
14 |
Unknown †
|
Vitamin K as Additive Treatment in Osteoporosis
Condition: |
Post-Menopausal Osteoporosis |
Interventions: |
Drug: Phylloquinone; Drug: Menaquinone (MK4); Drug: placebo |
Outcome Measures: |
Primary outcome measures- Changes in BMD at the Lumber spine, hip, fore-arm at 18 months.; Secondary outcome measure- Bone Turnover as assessed by the biochemical markers (serum CTX, P1NP, BALP, carboxylated and undercarboxylated osteocalcin (OC), OPG). These markers will be measured at the same time point during each clinic visit. |
|
15 |
Not yet recruiting
|
Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Condition: |
Osteoporosis Pseudoglioma Syndrome |
Intervention: |
Biological: Human recombinant growth hormone |
Outcome Measures: |
Bone quality by pQCT; Body fat percent |
|
16 |
Recruiting
|
Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Condition: |
Osteoporosis |
Intervention: |
Drug: Teriparatide |
Outcome Measure: |
Change in cortical thickness at the radius and tibia as measured by high-resolution quantitative computer tomography (HR-pQCT) |
|
17 |
Not yet recruiting
|
C-STOP Fracture Trial
Condition: |
Osteoporosis |
Interventions: |
Other: case management; Other: Multifaceted quality improvement intervention |
Outcome Measure: |
Proportion of untreated patients newly starting prescription Osteoporosis treatment with a bisphosphonate after their fracture |
|
18 |
Unknown †
|
Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids
Condition: |
Osteoporosis |
Intervention: |
Device: Dual energy X-ray absorptiometry |
Outcome Measure: |
Diagnosis of Osteoporosis |
|
19 |
Not yet recruiting
|
Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women
Condition: |
Primary Osteoporosis |
Intervention: |
|
Outcome Measures: |
Bone Mineral Density; SF-36; international Osteoporosis foundation ONE-MINUTE Osteoporosis RISK TEST; Markers of bone metabolism test; EQ-5D; Hepatic-renal function test; thyroid stimulating hormone level test |
|
20 |
Recruiting
|
Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis
Condition: |
Severe Osteoporosis |
Intervention: |
Drug: PREOB® Intravenous Infusion |
Outcome Measures: |
Cell biodistribution after intravenous infusion as assessed by SPECT/CT scan; Potential occurrence of any AE or SAE, related to the product, using patient open non-directive questionnaire, physical examination and laboratory measurements; Pain measured by the Visual Analogue Scale; Well-being score using SF-36 questionnaire; Occurrence of new vertebral fractures as assessed by X-ray; Bone mineral density evolution as assessed by Dual-energy X-ray absorptiometry (DEXA); Measurement of bone formation and resorption markers |
|